Global Pemetrexed Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 57393
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Pemetrexed market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Pemetrexed size is estimated to be xx million in 2021 from USD 1773.1 million in 2020, with a change of XX% between 2020 and 2021. The global Pemetrexed market size is expected to grow at a CAGR of 0.7% for the next five years.

Market segmentation

Pemetrexed market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

100mg

500mg

Market segment by Application can be divided into

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

The key market players for global Pemetrexed market are listed below:

Eli Lilly

Abbott Laboratories

Cadila Healthcare

Eagle Pharmaceuticals

Stada Arzneimittel

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Pemetrexed product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Pemetrexed, with price, sales, revenue and global market share of Pemetrexed in 2018 and 2019.

Chapter 3, the Pemetrexed competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Pemetrexed breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pemetrexed market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Pemetrexed sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Pemetrexed Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Pemetrexed Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 100mg

1.2.3 500mg

1.3 Market Analysis by Application

1.3.1 Overview: Global Pemetrexed Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Pemetrexed Market Size & Forecast

1.4.1 Global Pemetrexed Sales in Value (2016-2026))

1.4.2 Global Pemetrexed Sales in Volume (2016-2026)

1.4.3 Global Pemetrexed Price by Type (2016-2026) & (USD/Unit)

1.5 Global Pemetrexed Production Capacity Analysis

1.5.1 Global Pemetrexed Total Production Capacity (2016-2026)

1.5.2 Global Pemetrexed Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Pemetrexed Market Drivers

1.6.2 Pemetrexed Market Restraints

1.6.3 Pemetrexed Trends Analysis

2 Manufacturers Profiles

2.1 Eli Lilly

2.1.1 Eli Lilly Details

2.1.2 Eli Lilly Major Business

2.1.3 Eli Lilly Pemetrexed Product and Services

2.1.4 Eli Lilly Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Abbott Laboratories

2.2.1 Abbott Laboratories Details

2.2.2 Abbott Laboratories Major Business

2.2.3 Abbott Laboratories Pemetrexed Product and Services

2.2.4 Abbott Laboratories Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Cadila Healthcare

2.3.1 Cadila Healthcare Details

2.3.2 Cadila Healthcare Major Business

2.3.3 Cadila Healthcare Pemetrexed Product and Services

2.3.4 Cadila Healthcare Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Eagle Pharmaceuticals

2.4.1 Eagle Pharmaceuticals Details

2.4.2 Eagle Pharmaceuticals Major Business

2.4.3 Eagle Pharmaceuticals Pemetrexed Product and Services

2.4.4 Eagle Pharmaceuticals Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Stada Arzneimittel

2.5.1 Stada Arzneimittel Details

2.5.2 Stada Arzneimittel Major Business

2.5.3 Stada Arzneimittel Pemetrexed Product and Services

2.5.4 Stada Arzneimittel Pemetrexed Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Pemetrexed Sales by Manufacturer

3.1 Global Pemetrexed Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Pemetrexed Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Pemetrexed

3.4 Market Concentration Rate

3.4.1 Top 3 Pemetrexed Manufacturer Market Share

3.4.2 Top 6 Pemetrexed Manufacturer Market Share

3.5 Global Pemetrexed Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Pemetrexed Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Pemetrexed Market Size by Region

4.1.1 Global Pemetrexed Sales in Volume by Region (2016-2026)

4.1.2 Global Pemetrexed Revenue by Region (2016-2026)

4.2 North America Pemetrexed Revenue (2016-2026)

4.3 Europe Pemetrexed Revenue (2016-2026)

4.4 Asia-Pacific Pemetrexed Revenue (2016-2026)

4.5 South America Pemetrexed Revenue (2016-2026)

4.6 Middle East and Africa Pemetrexed Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Pemetrexed Sales in Volume by Type (2016-2026)

5.2 Global Pemetrexed Revenue by Type (2016-2026)

5.3 Global Pemetrexed Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Pemetrexed Sales in Volume by Application (2016-2026)

6.2 Global Pemetrexed Revenue by Application (2016-2026)

6.3 Global Pemetrexed Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Pemetrexed Sales by Type (2016-2026)

7.2 North America Pemetrexed Sales by Application (2016-2026)

7.3 North America Pemetrexed Market Size by Country

7.3.1 North America Pemetrexed Sales in Volume by Country (2016-2026)

7.3.2 North America Pemetrexed Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Pemetrexed Sales by Type (2016-2026)

8.2 Europe Pemetrexed Sales by Application (2016-2026)

8.3 Europe Pemetrexed Market Size by Country

8.3.1 Europe Pemetrexed Sales in Volume by Country (2016-2026)

8.3.2 Europe Pemetrexed Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Pemetrexed Sales by Type (2016-2026)

9.2 Asia-Pacific Pemetrexed Sales by Application (2016-2026)

9.3 Asia-Pacific Pemetrexed Market Size by Region

9.3.1 Asia-Pacific Pemetrexed Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Pemetrexed Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Pemetrexed Sales by Type (2016-2026)

10.2 South America Pemetrexed Sales by Application (2016-2026)

10.3 South America Pemetrexed Market Size by Country

10.3.1 South America Pemetrexed Sales in Volume by Country (2016-2026)

10.3.2 South America Pemetrexed Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Pemetrexed Sales by Type (2016-2026)

11.2 Middle East & Africa Pemetrexed Sales by Application (2016-2026)

11.3 Middle East & Africa Pemetrexed Market Size by Country

11.3.1 Middle East & Africa Pemetrexed Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Pemetrexed Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Pemetrexed Typical Distributors

12.3 Pemetrexed Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Pemetrexed Revenue by Type, (USD Million), 2021-2026

Table 2. Global Pemetrexed Revenue by Application, (USD Million), 2021-2026

Table 3. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 4. Eli Lilly Major Business

Table 5. Eli Lilly Pemetrexed Product and Services

Table 6. Eli Lilly Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table 8. Abbott Laboratories Major Business

Table 9. Abbott Laboratories Pemetrexed Product and Services

Table 10. Abbott Laboratories Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Cadila Healthcare Basic Information, Manufacturing Base and Competitors

Table 12. Cadila Healthcare Major Business

Table 13. Cadila Healthcare Pemetrexed Product and Services

Table 14. Cadila Healthcare Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Eagle Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 16. Eagle Pharmaceuticals Major Business

Table 17. Eagle Pharmaceuticals Pemetrexed Product and Services

Table 18. Eagle Pharmaceuticals Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Stada Arzneimittel Basic Information, Manufacturing Base and Competitors

Table 20. Stada Arzneimittel Major Business

Table 21. Stada Arzneimittel Pemetrexed Product and Services

Table 22. Stada Arzneimittel Pemetrexed Sales (Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Global Pemetrexed Sales by Manufacturer (2019-2021e) & (Units)

Table 24. Global Pemetrexed Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 25. Market Position of Manufacturers in Pemetrexed, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 26. Global Pemetrexed Production Capacity by Company, (Units): 2020 VS 2021

Table 27. Head Office and Pemetrexed Production Site of Key Manufacturer

Table 28. Pemetrexed New Entrant and Capacity Expansion Plans

Table 29. Pemetrexed Mergers & Acquisitions in the Past Five Years

Table 30. Global Pemetrexed Sales by Region (2016-2021e) & (Units)

Table 31. Global Pemetrexed Sales by Region (2021-2026) & (Units)

Table 32. Global Pemetrexed Revenue by Region (2016-2021e) & (USD Million)

Table 33. Global Pemetrexed Revenue by Region (2021-2026) & (USD Million)

Table 34. Global Pemetrexed Sales by Type (2016-2021e) & (Units)

Table 35. Global Pemetrexed Sales by Type (2021-2026) & (Units)

Table 36. Global Pemetrexed Revenue by Type (2016-2021e) & (USD Million)

Table 37. Global Pemetrexed Revenue by Type (2021-2026) & (USD Million)

Table 38. Global Pemetrexed Price by Type (2016-2021e) & (USD/Unit)

Table 39. Global Pemetrexed Price by Type (2021-2026) & (USD/Unit)

Table 40. Global Pemetrexed Sales by Application (2016-2021e) & (Units)

Table 41. Global Pemetrexed Sales by Application (2021-2026) & (Units)

Table 42. Global Pemetrexed Revenue by Application (2016-2021e) & (USD Million)

Table 43. Global Pemetrexed Revenue by Application (2021-2026) & (USD Million)

Table 44. Global Pemetrexed Price by Application (2016-2021e) & (USD/Unit)

Table 45. Global Pemetrexed Price by Application (2021-2026) & (USD/Unit)

Table 46. North America Pemetrexed Sales by Country (2016-2021e) & (Units)

Table 47. North America Pemetrexed Sales by Country (2021-2026) & (Units)

Table 48. North America Pemetrexed Revenue by Country (2016-2021e) & (USD Million)

Table 49. North America Pemetrexed Revenue by Country (2021-2026) & (USD Million)

Table 50. North America Pemetrexed Sales by Type (2016-2021e) & (Units)

Table 51. North America Pemetrexed Sales by Type (2021-2026) & (Units)

Table 52. North America Pemetrexed Sales by Application (2016-2021e) & (Units)

Table 53. North America Pemetrexed Sales by Application (2021-2026) & (Units)

Table 54. Europe Pemetrexed Sales by Country (2016-2021e) & (Units)

Table 55. Europe Pemetrexed Sales by Country (2021-2026) & (Units)

Table 56. Europe Pemetrexed Revenue by Country (2016-2021e) & (USD Million)

Table 57. Europe Pemetrexed Revenue by Country (2021-2026) & (USD Million)

Table 58. Europe Pemetrexed Sales by Type (2016-2021e) & (Units)

Table 59. Europe Pemetrexed Sales by Type (2021-2026) & (Units)

Table 60. Europe Pemetrexed Sales by Application (2016-2021e) & (Units)

Table 61. Europe Pemetrexed Sales by Application (2021-2026) & (Units)

Table 62. Asia-Pacific Pemetrexed Sales by Region (2016-2021e) & (Units)

Table 63. Asia-Pacific Pemetrexed Sales by Region (2021-2026) & (Units)

Table 64. Asia-Pacific Pemetrexed Revenue by Region (2016-2021e) & (USD Million)

Table 65. Asia-Pacific Pemetrexed Revenue by Region (2021-2026) & (USD Million)

Table 66. Asia-Pacific Pemetrexed Sales by Type (2016-2021e) & (Units)

Table 67. Asia-Pacific Pemetrexed Sales by Type (2021-2026) & (Units)

Table 68. Asia-Pacific Pemetrexed Sales by Application (2016-2021e) & (Units)

Table 69. Asia-Pacific Pemetrexed Sales by Application (2021-2026) & (Units)

Table 70. South America Pemetrexed Sales by Country (2016-2021e) & (Units)

Table 71. South America Pemetrexed Sales by Country (2021-2026) & (Units)

Table 72. South America Pemetrexed Revenue by Country (2016-2021e) & (USD Million)

Table 73. South America Pemetrexed Revenue by Country (2021-2026) & (USD Million)

Table 74. South America Pemetrexed Sales by Type (2016-2021e) & (Units)

Table 75. South America Pemetrexed Sales by Type (2021-2026) & (Units)

Table 76. South America Pemetrexed Sales by Application (2016-2021e) & (Units)

Table 77. South America Pemetrexed Sales by Application (2021-2026) & (Units)

Table 78. Middle East & Africa Pemetrexed Sales by Country (2016-2021e) & (Units)

Table 79. Middle East & Africa Pemetrexed Sales by Country (2021-2026) & (Units)

Table 80. Middle East & Africa Pemetrexed Revenue by Country (2016-2021e) & (USD Million)

Table 81. Middle East & Africa Pemetrexed Revenue by Country (2021-2026) & (USD Million)

Table 82. Middle East & Africa Pemetrexed Sales by Type (2016-2021e) & (Units)

Table 83. Middle East & Africa Pemetrexed Sales by Type (2021-2026) & (Units)

Table 84. Middle East & Africa Pemetrexed Sales by Application (2016-2021e) & (Units)

Table 85. Middle East & Africa Pemetrexed Sales by Application (2021-2026) & (Units)

Table 86. Direct Channel Pros & Cons

Table 87. Indirect Channel Pros & Cons

Table 88. Pemetrexed Typical Distributors

Table 89. Pemetrexed Typical Customers

List of Figures

Figure 1. Pemetrexed Picture

Figure 2. Global Pemetrexed Sales Market Share by Type in 2020

Figure 3. 100mg

Figure 4. 500mg

Figure 5. Global Pemetrexed Sales Market Share by Application in 2020

Figure 6. Hospital Pharmacies

Figure 7. Retail Pharmacies

Figure 8. Online Pharmacies

Figure 9. Global Pemetrexed Market Size, (USD Million) & (Units): 2020 VS 2021 VS 2026

Figure 10. Global Pemetrexed Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Pemetrexed Sales (2016-2026) & (Units)

Figure 12. Global Pemetrexed Price by Type (2016-2026) & (USD/Unit)

Figure 13. Global Pemetrexed Production Capacity (2016-2026) & (Units)

Figure 14. Global Pemetrexed Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Pemetrexed Market Drivers

Figure 16. Pemetrexed Market Restraints

Figure 17. Pemetrexed Market Trends

Figure 18. Global Pemetrexed Sales Market Share by Manufacturer in 2020

Figure 19. Global Pemetrexed Revenue Market Share by Manufacturer in 2020

Figure 20. Pemetrexed Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Pemetrexed Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Pemetrexed Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Pemetrexed Sales Market Share by Region (2016-2026)

Figure 24. Global Pemetrexed Revenue Market Share by Region (2016-2026)

Figure 25. North America Pemetrexed Revenue (2016-2026) & (USD Million)

Figure 26. Europe Pemetrexed Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Pemetrexed Revenue (2016-2026) & (USD Million)

Figure 28. South America Pemetrexed Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Pemetrexed Revenue (2016-2026) & (USD Million)

Figure 30. Global Pemetrexed Sales Market Share by Type (2016-2026)

Figure 31. Global Pemetrexed Revenue Market Share by Type (2016-2026)

Figure 32. Global Pemetrexed Price by Type (2016-2026) & (USD/Unit)

Figure 33. Global Pemetrexed Sales Market Share by Application (2016-2026)

Figure 34. Global Pemetrexed Revenue Market Share by Application (2016-2026)

Figure 35. Global Pemetrexed Price by Application (2016-2026) & (USD/Unit)

Figure 36. North America Pemetrexed Sales Market Share by Type (2016-2026)

Figure 37. North America Pemetrexed Sales Market Share by Application (2016-2026)

Figure 38. North America Pemetrexed Sales Market Share by Country (2016-2026)

Figure 39. North America Pemetrexed Revenue Market Share by Country (2016-2026)

Figure 40. United States Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Pemetrexed Sales Market Share by Type (2016-2026)

Figure 44. Europe Pemetrexed Sales Market Share by Application (2016-2026)

Figure 45. Europe Pemetrexed Sales Market Share by Country (2016-2026)

Figure 46. Europe Pemetrexed Revenue Market Share by Country (2016-2026)

Figure 47. Germany Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Pemetrexed Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Pemetrexed Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Pemetrexed Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Pemetrexed Revenue Market Share by Region (2016-2026)

Figure 56. China Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Pemetrexed Sales Market Share by Type (2016-2026)

Figure 63. South America Pemetrexed Sales Market Share by Application (2016-2026)

Figure 64. South America Pemetrexed Sales Market Share by Country (2016-2026)

Figure 65. South America Pemetrexed Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Pemetrexed Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Pemetrexed Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Pemetrexed Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Pemetrexed Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Pemetrexed Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source